Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Nature Medicine2015Vol. 21(10), pp. 1163–1171
Citations Over TimeTop 1% of 2015 papers
Paweł K. Mazur, Alexander Herner, Stephano S. Mello, Matthias Wirth, Simone Hausmann, Francisco J. Sánchez‐Rivera, Shane Lofgren, Timo Kuschma, Stephan A. Hahn, Deepak Vangala, Marija Trajkovic‐Arsic, Aayush Gupta, Irina Heid, Peter B. Noël, Rickmer Braren, Mert Erkan, Jörg Kleeff, Bence Sipos, Leanne C. Sayles, Mathias Heikenwälder, Elisabeth Heßmann, Volker Ellenrieder, Iréne Esposito, Tyler Jacks, James E. Bradner, Purvesh Khatri, E. Alejandro Sweet‐Cordero, Laura D. Attardi, Roland M. Schmid, Guenter Schneider, Julien Sage, Jens T. Siveke
Related Papers
- → Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update(2020)82 cited
- → Epigenetic Therapy for Breast Cancer(2011)46 cited
- → Epigenetic therapy of hematological malignancies: where are we now?(2012)25 cited
- → Molecular Targets for Epigenetic Therapy of Cancer(2009)16 cited
- → Epigenetic Therapy should be in the Tool Box for Recurrent Ovarian Cancer(2020)